Company: NIVFW
Filing Date: 2025-09-15
Form Type: F-1
Source: 0001213900-25-087717
Chunk: 33

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-15
Form: F-1
Chunk 33
---
 the requirements to report transactions in our equity securities and from the short-swing profit liability provisions contained in Section 16 of the Exchange Act. As a foreign private issuer, we are not subject to the requirements of Regulation FD (Fair Disclosure) promulgated under the Exchange Act. In addition, as a foreign private issuer, we are permitted to follow certain home country corporate governance practices instead of those otherwise required under the rules of Nasdaq for domestic U.S. issuers and are not required to be compliant with all Nasdaq rules as of the date of our initial listing on Nasdaq as would domestic U.S. issuers. These exemptions and leniencies will reduce the frequency and scope of information and protections available to you in comparison to those applicable to a U.S. domestic reporting company. We intend to take advantage of the exemptions available to us as a foreign private issuer. Summary of Risk Factors Investing in our Class A Ordinary Shares involves significant risks. You should carefully consider all of the information in this prospectus before making an investment in our shares. Below please find a summary of the principal risks we face, organized under relevant headings. These risks are discussed more fully in the section titled “ Risk Factors” and in Part I, Item 3, D. Risk Factors in our most recent Annual Report on Form 20-F. Risks Related to NewGenIvf’s Business and Industry

| ● | We may not be able to continue operating as a going concern.                                                                                                                                          |
| ● | The fertility market in which NewGenIvf participates is competitive, and if NewGenIvf does not continue to compete effectively, its results of operations could be materially and adversely affected. |
| ● | NewGenIvf has a limited operating history with its current platform of solutions, which makes it difficult to predict its future prospects, financial performance and results of operations.          |
| ● | Our planned Solana strategy                                                                                                                                                                           
 may not be successful and exposes us to various risks, including risks associated with the Solana network, SOL token and the blockchain                                                               
 sector.                                                                                                                                                                                               |

| ● | Our Solana digital asset                                                                                                           
 staking strategy is subject to unique and substantial risks related to the Solana network’s technology, governance, and ecosystem, 
 which could result in a complete or partial loss of our investment.                                                                |
| ● | SOL is a relatively                                                                                                                
 novel digital asset, and is subject to significant legal, commercial, regulatory and technical uncertainty, which could materially 
 adversely affect the Company’s financial position, operations